Evommune (EVMN) Change in Account Payables (2024 - 2026)
Evommune's (EVMN) quarterly Change in Account Payables came in at -$3.7 million in Q1 2026, down 442.55% year-on-year from $1.1 million in Q1 2025, and down 197.35% on a QoQ basis from $3.9 million in Q4 2025.
Evommune (EVMN) Change in Account Payables (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Change in Account Payables data on file, last reported at -$3.7 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 442.55% year-over-year to -$3.7 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$837000.0, down 112.87% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$3.7 million, down from $3.9 million in the prior quarter.
- Over the last five years, Change in Account Payables for EVMN reached as high as $3.9 million in Q4 2025 and fell as low as -$3.7 million in Q1 2026.
- Historically, Change in Account Payables has averaged $566250.0 across 3 years, with a median of $1.1 million in 2024.
- Across the five-year window, Change in Account Payables jumped 34.93% in 2025 and sank 442.55% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at $2.9 million in 2024, then jumped by 34.93% to $3.9 million in 2025, then slumped by 197.35% to -$3.7 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$3.7 million in Q1 2026, $3.9 million in Q4 2025, and -$691000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Evommune | 381.48 Mn | 170.02 Mn | - | -3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.75 Mn |
| Mar 31, 2026 | -3.75 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | -691,000.00 |
| Mar 31, 2025 | -691,000.00 |
| Dec 31, 2024 | 2.85 Mn |
| Dec 31, 2024 | 2.85 Mn |